FDA accepts AstraZeneca's new drug application for constipation drug

The US Food and Drug Administration (FDA) has accepted AstraZeneca's new drug application (NDA) for naloxegol, an investigational peripherally acting mu-opioid receptor antagonist (PAMORA) for the treatment of opioid-induced constipation (OIC).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news